Our clinical trials

Phase Ib /II Clinical Trial of Nivolumab Monotherapy and Nivolumab in Combination with Ipilimumab in Pediatric Subjects with High Grade Primary CNS Malignancies.

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion

Phase I-II study of nivolumab in combination;with temozolomide and radiotherapy;in children and adolescents;with newly diagnosed high-grade glioma